^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Rhitol (allodepleted T-cell immunotherapeutics)

    i
    Other names: TH9402, ATIR-101, ATIR, TH-9402, T-lymphocyte enriched leukocyte preparation depleted ex vivo of host alloreactive T-cells using photodynamic treatment, Theralux-ATIR, ATIR101, TH 9402
    Associations

    News

    Trials
    Company:
    Sanofi
    Drug class:
    Immunomodulator, T lymphocyte replacement
    Related drugs:
    Associations

    News

    Trials
    over2years
    HATCY: Safety and Efficacy of ATIR101 as Adjunctive Treatment to Blood Stem Cell Transplantation From a Haploidentical Family Donor Compared to Post-transplant Cyclophosphamide in Patients With Blood Cancer (clinicaltrials.gov)
    P3, N=63, Terminated, Kiadis Pharma | Active, not recruiting --> Terminated; Insufficient efficacy, terminated by Sponsor
    Preclinical • Trial termination
    |
    HLA-DRB1 (Major Histocompatibility Complex, Class II, DR Beta 1) • HLA-B (Major Histocompatibility Complex, Class I, B) • HLA-C (Major Histocompatibility Complex, Class I, C)
    |
    cyclophosphamide • Rhitol (allodepleted T-cell immunotherapeutics)